First Dallas Securities’s GSK GSK Stock Holding History

First Dallas Securities’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-3,212	Closed	-$142K	–	115
2017 Q4	$142K	Buy	+3,212	New	+$148K	0.09%	118
2016 Q4	–	Sell	-5,092	Closed	-$274K	–	112
2016 Q3	$274K	Sell	5,092 -200	-4%	-$11K	0.2%	84
2016 Q2	$287K	Sell	5,292 -380	-7%	-$20K	0.22%	83
2016 Q1	$287K	Sell	5,672 -252	-4%	-$12.6K	0.23%	79
2015 Q4	$299K	Buy	5,924 +1,520	+35%	+$77.5K	0.24%	75
2015 Q3	$212K	Sell	4,404 -1,720	-28%	-$89.5K	0.17%	87
2015 Q2	$319K	Sell	6,124 -148	-2%	-$8.33K	0.23%	72
2015 Q1	$362K	Sell	6,272 -376	-6%	-$21.6K	0.25%	65
2014 Q4	$355K	Sell	6,648 -196	-3%	-$11K	0.23%	71
2014 Q3	$393K	Sell	6,844 -172	-2%	-$10.5K	0.23%	68
2014 Q2	$469K	Sell	7,016 -496	-7%	-$33.6K	0.28%	63
2014 Q1	$502K	Sell	7,512 -312	-4%	-$21.1K	0.34%	58
2013 Q4	$522K	Sell	7,824 -184	-2%	-$11.9K	0.35%	54
2013 Q3	$502K	Sell	8,008 -40	-0.5%	-$2.58K	0.38%	51
2013 Q2	$503K	Buy	+8,048	New	+$511K	0.39%	51

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

First Dallas Securities's GSK Position: Q1 2018 in Review

First Dallas Securities sold out of GSK (GSK) in Q1 2018, closing a stake of 3,212 shares — an estimated $142K sold.

First Dallas Securities first reported a position in GSK in Q2 2013 and held it in 15 quarters. The position peaked at $522K in Q4 2013. 778 funds tracked by Wall St. Rank hold GSK as of Q1 2018.

First Dallas Securities reported no remaining GSK position as of Q1 2018 after selling out during the quarter.
First Dallas Securities sold 3,212 GSK shares in Q1 2018, an estimated $142K.
First Dallas Securities first reported a position in GSK in Q2 2013 and held it in 15 quarters.
First Dallas Securities's GSK position peaked at $522K in Q4 2013.
778 funds tracked by Wall St. Rank held GSK as of Q1 2018.

Based on First Dallas Securities's 13F filing for Q1 2018, filed 4 May 2018.